ArticleMolecular therapy. Methods & clinical development2022

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an

Kimberly B Viker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.